SEA-PAP High Oscillation Continuous Positive Airway Pressure Device

NeoRest team at the Seattle Children's Hospital

Product description Brand name and product description

The Seattle Children’s Hospital High Oscillation Continuous Positive Airway Pressure (Sea-PAP) Device is a respiratory support technology for infants. The NeoRest Team claims that Sea-PAP improves upon conventional bCPAP by more consistently producing a range of oscillations thought to improve lung function and make it easier for an infant to breathe.

Target region(s) Target region for distribution/implementation (listed by country if specified)

Resource-limited countries, especially countries in Africa, Asia and South America.

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

The NeoRest Team is in the process of finalizing the Sea-PAP device design, identifying manufacturers to produce the device and preparing to conduct clinical trials. It is not being distributed widely at this time.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

Prototype. No pricing information yet available.

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

Infant ventilators, such as those from Heyer Medical AG, Hamilton Medical. Pumani bCPAP

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: to improve and promote good health.

Decrease in neonatal mortality related to respiratory distress syndrome.

Target user(s) Target user/consumer base (country, income segment)
The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F